MFDS — authorised 3 July 1951
- Marketing authorisation holder: SHIRE
- Status: likely_approved
🇰🇷 Banthine in South Korea
MFDS authorised Banthine on 3 July 1951
Marketing authorisation
Banthine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Banthine approved in South Korea?
Yes. MFDS authorised it on 3 July 1951.
Who is the marketing authorisation holder for Banthine in South Korea?
SHIRE holds the South Korean marketing authorisation.